ALEMBIC PHARMA Fact Sheet, ALEMBIC PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Fact Sheet    (APLL)



Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC PHARMA Price History

Price Rs 897.0
Mkt Cap Rs m 169,093
Vol '000 9.7
P/E X 21.0
P/CF X 23.9
EPS (TTM) Rs 42.7
% ch % -0.4
No. of shares m 188.52
% ch week % -0.7
% ch 1-mth % 5.2
% ch 12-mth % 69.6
52 week H/L Rs 984.0/436.1
(As on Jul 3, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
ALEMBIC PHARMA EQUITY SHARE DATA
High Rs495792709645664 
Low Rs228443516470412 
Sales per share (Unadj.) Rs109.1167.0166.3166.1208.7 
Earnings per share (Unadj.) Rs15.038.221.421.931.0 
Diluted earnings per shareRs15.038.221.421.931.0 
Cash flow per share (Unadj.) Rs17.442.025.827.537.1 
Dividends per share (Unadj.) Rs3.504.004.004.005.50 
Adj. dividends per shareRs3.504.004.004.005.50 
Dividend yield (eoy) %1.00.60.70.71.0 
Book value per share (Unadj.) Rs46.984.9100.9117.8144.2 
Adj. book value per shareRs46.984.9100.9117.8144.2 
Shares outstanding (eoy) m188.52188.52188.52188.52188.52 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.33.73.73.42.6 
Avg P/E ratio x24.116.228.625.517.4 
P/CF ratio (eoy) x20.814.723.820.314.5 
Price / Book Value ratio x7.77.36.14.73.7 
Dividend payout %23.310.518.718.317.7 
Avg Mkt Cap Rs m68,122116,383115,459105,090101,461 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,0684,2145,5886,2287,467 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC PHARMA INCOME DATA
Net Sales Rs m20,56131,48731,34631,30839,347 
Other income Rs m2355207094 
Total revenues Rs m20,58431,54231,36631,37839,441 
Gross profit Rs m4,03010,0606,1536,4318,736 
Depreciation Rs m4447228301,0551,152 
Interest Rs m18375234184 
Profit before tax Rs m3,5919,3565,2915,4137,493 
Minority Interest Rs m000011 
Prior Period Items Rs m2-2-38-81-93 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7642,1601,2221,2041,568 
Profit after tax Rs m2,8297,1944,0314,1285,844 
Gross profit margin %19.631.919.620.522.2 
Effective tax rate %21.323.123.122.220.9 
Net profit margin %13.822.812.913.214.9 
ALEMBIC PHARMA BALANCE SHEET DATA
Current assets Rs m8,90715,06613,72518,24719,577 
Current liabilities Rs m6,8417,6746,92711,23514,896 
Net working cap to sales %10.123.521.722.411.9 
Current ratio x1.32.02.01.61.3 
Inventory Days Days6867748690 
Debtors Days Days6441396145 
Net fixed assets Rs m5,9478,23711,95720,03527,097 
Share capital Rs m377377377377377 
"Free" reserves Rs m8,37415,41618,64621,82426,811 
Net worth Rs m8,84616,00519,02322,20127,188 
Long term debt Rs m188005,0004,993 
Total assets Rs m16,41224,59426,89339,41147,778 
Interest coverage x202.7255.2102.2160.241.7 
Debt to equity ratio x0000.20.2 
Sales to assets ratio x1.31.31.20.80.8 
Return on assets %17.329.415.210.612.6 
Return on equity %32.044.921.218.621.5 
Return on capital %40.058.727.919.723.6 
Exports to sales %39.355.749.846.40 
Imports to sales %10.010.410.310.50 
Exports (fob) Rs m8,08517,55115,62614,5350 
Imports (cif) Rs m2,0503,2833,2413,2880 
Fx inflow Rs m8,28417,81115,80614,72219,453 
Fx outflow Rs m3,1475,3185,2897,0266,065 
Net fx Rs m5,13712,49310,5177,69613,388 
ALEMBIC PHARMA CASH FLOW
From Operations Rs m 1,718 9,304 3,286 3,124 8,120 
From Investments Rs m -2,556 -3,105 -4,859 -8,844 -7,556 
From Financial Activity Rs m 867 -1,959 -1,289 5,026 590 
Net Cashflow Rs m 29 4,240 -2,862 -693 1,153 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.1%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.9%
FIIs 9.1%
ADR/GDR 0.0%
Free float 13.9%
Shareholders 49,328
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, ,Vadodara,Gujarat - 390 003
E-MAIL apl.investors@alembic.co.in WEB www.alembic-india.com
TELEPHONE (0265) 2282 550 FAX (0265) 2282 506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Rajkumar Baheti YEAR OF INC: 2010 BSE CODE: 533573 FV (Rs): 2 DIV YIELD (%): 0.6

Read: ALEMBIC PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  PROCTER & GAMBLE HEALTH  INDRAPRASTHA MEDICAL  UNICHEM LAB  PFIZER  

Compare ALEMBIC PHARMA With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  INDRAPRASTHA MEDICAL  UNICHEM LAB  PFIZER  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

MoD Approves Defence Purchases, Vedanta's Delisting, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Friday. Benchmark indices edged higher as positive developments in a coronavirus vaccine trial improved global risk sentiment.

Views on news

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - ADCOCK INGRAM COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS